Drug Shortage Report for GD-AMLODIPINE/ATORVASTATIN

Last updated on 2020-04-22 History
Report ID 103957
Drug Identification Number 02362821
Brand name GD-AMLODIPINE/ATORVASTATIN
Common or Proper name Amlodipine/Atorvastatin
Company Name UPJOHN CANADA ULC
Market Status MARKETED
Active Ingredient(s) AMLODIPINE ATORVASTATIN
Strength(s) 10MG 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90's
ATC code C10BX
ATC description LIPID MODIFYING AGENTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-22
Estimated end date
Actual end date 2020-04-21
Shortage status Resolved
Updated date 2020-04-22
Company comments
Health Canada comments
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-833-287-5646 Email / courriel: UpjohnCanadaCustomerService@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2020-04-22 French Compare
v10 2020-04-22 English Compare
v9 2020-03-31 French Compare
v8 2020-03-31 English Compare
v7 2020-03-31 French Compare
v6 2020-03-31 English Compare
v5 2020-02-18 French Compare
v4 2020-02-18 English Compare
v3 2020-01-23 English Compare
v2 2020-01-22 French Compare
v1 2020-01-22 English Compare